The Irish Times reported that the Department of Health confirmed that it the Health Service Executive (HSE) cannot fund 4 medicines from within its budget. Under these circumstances (through the rules introduced in 2013), the Department can bring a memorandum to Government requesting additional funding for it.
So far, only one memo has been brought forward, for the cystic fibrosis drugs Orkambi and Kalydeco, while the Department is considering three other medicines for approval.
An HSE spokeswoman said “while the HSE strives to reach a decision regarding drug approval in as timely a manner as possible, because of the significant monies involved, there is an onus to ensure that the best price is achieved as these commitments often feature multi-million euro investments on an ongoing basis.”
Read the original article from FirstWordPharma.